Pancreatic Cancer Research

ResearcherShenzhen UniversityActive in the last 2 years

Dan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5904-871X; OpenAlex author ID A5100380655. Sources: OpenAlex.

Their work

Papers
9 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 2 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 3 papers · 2023: none · 2024: 1 paper

Papers 9

  1. Photo-Triggered Cascade Therapy: A NIR-II AIE Luminogen Collaborating with Nitric Oxide Facilitates Efficient Collagen Depletion for Boosting Pancreatic Cancer… Co-author DOI 10.1002/adma.202306476↗
  2. Synchronously boosting type-I photodynamic and photothermal efficacies via molecular manipulation for pancreatic cancer theranostics in the NIR-II window. Co-author DOI 10.1016/j.biomaterials.2022.121476↗
  3. Phenotypic profiling of pancreatic ductal adenocarcinoma plasma-derived small extracellular vesicles for cancer diagnosis and cancer stage prediction: a proof-… Co-author DOI 10.1039/d2ay00536k↗
  4. Sensitive and selective detection of Mucin1 in pancreatic cancer using hybridization chain reaction with the assistance of Fe3O4@polydopamine nanocomposites. Co-author DOI 10.1186/s12951-022-01289-w↗
  5. Functionalized Graphene@Gold Nanostar/Lipid for Pancreatic Cancer Gene and Photothermal Synergistic Therapy under Photoacoustic/Photothermal Imaging Dual-Modal… Co-author DOI 10.1002/smll.202003707↗
  6. A small-molecule induces apoptosis and suppresses metastasis in pancreatic cancer cells. Co-author DOI 10.1016/j.ejps.2012.12.023↗
  7. Selective induction of apoptosis: promising therapy in pancreatic cancer. First author DOI 10.2174/1381612811319120013↗
  8. Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells. First author DOI 10.1159/000337103↗
  9. A potent lead induces apoptosis in pancreatic cancer cells. First author DOI 10.1371/journal.pone.0037841↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Erkang Wang · 6 shared papers, 2012–2022 · strength 0.57
  2. Yuling Wang · 3 shared papers, 2020–2022 · strength 0.44
  3. Jian Ji · 2 shared papers, 2022–2024 · strength 0.39
  4. Ben Zhong Tang · 2 shared papers, 2022–2024 · strength 0.39
  5. Xiaohui Chen · 2 shared papers, 2022–2024 · strength 0.39
  6. Jin Wang · 4 shared papers, 2013–2022 · strength 0.37
  7. Xiuna Jia · 2 shared papers, 2020–2022 · strength 0.28
  8. Zuojia Liu · 4 shared papers, 2012–2013 · strength 0.17
  9. Qing Dong · 1 shared paper, 2022 · strength 0.16
  10. Wei Zhang · 1 shared paper, 2022 · strength 0.16
  11. Fenglan Niu · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.